Cingulate Inc. ( CING) - Stock Earnings
CING Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
CING Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -6.3 million USD | — USD |
| 2026Q1 | -9.3 million USD | — USD |
| 2026Q2 | -5.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CING Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.5 million USD | — USD |
| 2024 | -16.6 million USD | — USD |
| 2025 | -22.4 million USD | — USD |
| 2026 Est. | — | — |
CING
Price: $4.57
52 week price:
Earnings Per Share: -3.56 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16900
Market Capitalization: 65.9 million